Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization study
Lanlan Chen, Hongqun Yang, Haitao Li, Chang He, Liu Yang, Guoyue Lv – 7 October 2021
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay
Vinay Sundaram, Rajiv Jalan – 7 October 2021
Macrophage nuclear factor erythroid 2‐related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3–mediated RhoA/ROCK pathway in the ischemic liver
Jianhua Rao, Jiannan Qiu, Ming Ni, Hao Wang, Peng Wang, Lei Zhang, Zeng Wang, Mu Liu, Feng Cheng, Xuehao Wang, Ling Lu – 7 October 2021
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand
Jess Howell, Avik Majumdar, Michael A. Fink, Mandy Byrne, Geoff McCaughan, Simone I. Strasser, Michael Crawford, Peter Hodgkinson, Katherine A. Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C. Wallace, Stephen Munn, Ed Gane, Alex J.
A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients
Jieling Xiao, Jie Ning Yong, Cheng Han Ng, Nicholas Syn, Wen Hui Lim, Darren Jun Hao Tan, En Ying Tan, Daniel Huang, Raymond C. Wong, Nicholas W. S. Chew, Eunice Xiang Xuan Tan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 7 October 2021 – The shift in the changing etiology of cirrhosis requiring liver transplantation (LT) has resulted in an increasing prevalence of coronary artery disease (CAD) that can potentially impact post‐LT outcomes.
Reply
Femke H.C. Goeij, Andrea Schlegel, Philipp Dutkowski – 7 October 2021
Seroconversion After Coronavirus Disease 2019 Vaccination
Pathum Sookaromdee, Viroj Wiwanitkit – 6 October 2021
Introduction of the Concept of Diagnostic Sensitivity and Specificity of Normothermic Perfusion Protocols to Assess High‐Risk Donor Livers
Hynek Mergental, Richard W. Laing, James Hodson, Yuri L. Boteon, Joseph A. Attard, Laine L. Walace, Desley A. H. Neil, Darren Barton, Andrea Schlegel, Paolo Muiesan, Manuel Abradelo, John R. Isaac, Keith Roberts, M. Thamara P. R. Perera, Simon C. Afford, Darius F. Mirza – 6 October 2021 – Normothermic machine perfusion (NMP) allows objective assessment of donor liver transplantability. Several viability evaluation protocols have been established, consisting of parameters such as perfusate lactate clearance, pH, transaminase levels, and the production and composition of bile.
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal, Nabihah Tayob, Anand Mehta, Jorge A. Marrero, Hashem El‐Serag, Qingchun Jin, Cristian Saenz de Viteri, Austin Fobar, Neehar D. Parikh – 6 October 2021
Reply
Alberto Calleri, Margherita Saracco, Fabrizia Pittaluga, Rossana Cavallo, Renato Romagnoli, Silvia Martini – 6 October 2021